Results 41 to 50 of about 1,647,722 (237)

Cell type-specific genetic reconstitution of CB1 receptor subsets to assess their role in exploratory behaviour, sociability, and memory [PDF]

open access: yes, 2022
Several studies support the notion that exploratory behaviour depends on the functionality of the cannabinoid type 1 (CB1) receptor in a cell type-specific manner. Mice lacking the CB1 receptor in forebrain GABAergic or dorsal telencephalic glutamatergic
Häring, Martin   +4 more
core   +1 more source

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin

open access: yesCell Death and Disease, 2023
Statins are the most prescribed lipid-lowering agents worldwide. Their use is generally safe, although muscular toxicity occurs in about 1 in 10.000 patients.
Hilal Kalkan   +9 more
doaj   +1 more source

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

open access: yesPharmaceuticals, 2010
Cannabis contains the psychoactive component delta9-tetrahydrocannabinol (delta9-THC), and the non-psychoactive components cannabidiol (CBD), cannabinol, and cannabigerol.
Michihiro Fujiwara   +2 more
doaj   +1 more source

Signal transduction of the CB1 cannabinoid receptor [PDF]

open access: yesJournal of Molecular Endocrinology, 2009
The CB 1 cannabinoid receptor (CB 1 R) is the major cannabinoid receptor in neuronal cells and the brain, but it also occurs in endocrine cells and other peripheral tissues.
Gábor, Turu, László, Hunyady
openaire   +2 more sources

CB1 Cannabinoid Receptor Stimulation Modulates Transient Receptor Potential Vanilloid Receptor 1 Activities in Calcium Influx and Substance P Release in Cultured Rat Dorsal Root Ganglion Cells

open access: yesJournal of Pharmacological Sciences, 2005
Cannabinoids have been reported to have analgesic properties in animals of acute nociception or of inflammatory and neuropathic pain models, but the mechanisms by which they exert such alleviative effects are not yet fully understood.
Kyoko Oshita   +5 more
doaj   +1 more source

Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia

open access: yesFrontiers in Pharmacology, 2019
Alterations of the PI3K/Akt/mammalian target of rapamycin complex 1 (mTORC1) signaling pathway are causally involved in a subset of malformations of cortical development (MCDs) ranging from focal cortical dysplasia (FCD) to hemimegalencephaly and ...
Daniel García-Rincón   +21 more
doaj   +1 more source

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

open access: yesNeurobiology of Disease, 2005
We have observed that systemic administration of cannabinoid CB1 antagonists exerts antiparkinsonian effects in rats with very severe nigral lesion (>95% cell loss), but not in rats with less severe lesion (85–95% cell loss).
Emilio Fernandez-Espejo   +6 more
doaj   +1 more source

Developmental and visual input-dependent regulation of the CB1 cannabinoid receptor in the mouse visual cortex. [PDF]

open access: yesPLoS ONE, 2013
The mammalian visual system exhibits significant experience-induced plasticity in the early postnatal period. While physiological studies have revealed the contribution of the CB1 cannabinoid receptor (CB1) to developmental plasticity in the primary ...
Taisuke Yoneda   +5 more
doaj   +1 more source

Cardiorespiratory anomalies in mice lacking CB1 cannabinoid receptors. [PDF]

open access: yesPLoS ONE, 2014
Cannabinoid type 1 (CB1) receptors are expressed in the nervous and cardiovascular systems. In mice, CB1 receptor deficiency protects from metabolic consequences of a high-fat diet (HFD), increases sympathetic activity to brown fat, and entails sleep ...
Alessandro Silvani   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy